The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer

BACKGROUND: The immunologic constant of rejection (ICR) is a broad phenomenon of Th-1 immunity-mediated, tissue-specific destruction. METHODS: We tested the prognostic value of a 20-gene ICR expression signature in 8766 early breast cancers. RESULTS: Thirty-three percent of tumours were ICR1, 29% IC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Bertucci, François, Finetti, Pascal, Simeone, Ines, Hendrickx, Wouter, Wang, Ena, Marincola, Francesco M., Viens, Patrice, Mamessier, Emilie, Ceccarelli, Michele, Birnbaum, Daniel, Bedognetti, Davide
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6265245/
https://ncbi.nlm.nih.gov/pubmed/30353048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0309-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados